Literature DB >> 2450149

Localization of epidermal hyaluronic acid using the hyaluronate binding region of cartilage proteoglycan as a specific probe.

R Tammi1, J A Ripellino, R U Margolis, M Tammi.   

Abstract

Hyaluronate is actively synthesized by cultured epidermis and dermis, but no direct histological data have been available about its localization in normal human skin. A hyaluronate-specific biotinylated probe, prepared from the hyaluronate binding region of cartilage proteoglycan, was applied to human skin sections and visualized using the biotin-avidin-peroxidase system. The specificity of this staining was confirmed by hyaluronidase predigestion and by hyaluronate-derived oligosaccharides added to the staining solution. All dermis showed diffuse binding of the probe, but the highest staining intensity was observed in the epidermal intercellular spaces. The stainability extended from basal cells to the middle layers of the epidermis, whereas the granular layer and stratum corneum were completely negative. Also, the basal side of basal cells (basement membrane) did not bind the hyaluronate probe. The abundance of hyaluronate on surfaces and intercellular spaces of the spinous cells is suggested to have an important role in the physiology of human epidermis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2450149     DOI: 10.1111/1523-1747.ep12456530

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  59 in total

1.  Snake venom hyaluronidase: an evidence for isoforms and extracellular matrix degradation.

Authors:  K S Girish; D K Jagadeesha; K B Rajeev; K Kemparaju
Journal:  Mol Cell Biochem       Date:  2002-11       Impact factor: 3.396

2.  Distribution of hyaluronan and its CD44 receptor in the epithelia of human skin appendages.

Authors:  C Wang; M Tammi; R Tammi
Journal:  Histochemistry       Date:  1992-09

3.  Cell recovery during segmental intestinal perfusion in healthy subjects and patients with Crohn's disease.

Authors:  O Ahrenstedt; F Knutson; L Knutson; M Krog; O Sjöberg; R Hällgren
Journal:  Gut       Date:  1991-02       Impact factor: 23.059

4.  Ultrastructural localisation of anionic sites at the dermo-epidermal junction in normal human skin.

Authors:  J Nanchahal; D J Riches
Journal:  J Anat       Date:  1991-06       Impact factor: 2.610

5.  Binding of trastuzumab to ErbB2 is inhibited by a high pericellular density of hyaluronan.

Authors:  Tímea Váradi; Tamás Mersich; Päivi Auvinen; Raija Tammi; Markku Tammi; Ferenc Salamon; István Besznyák; Ferenc Jakab; Zsolt Baranyai; János Szöllősi; Peter Nagy
Journal:  J Histochem Cytochem       Date:  2012-05-04       Impact factor: 2.479

6.  Proteoglycans in Normal and Healing Skin.

Authors:  Margaret Mary Smith; James Melrose
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

Review 7.  Applications and emerging trends of hyaluronic acid in tissue engineering, as a dermal filler and in osteoarthritis treatment.

Authors:  A Fakhari; C Berkland
Journal:  Acta Biomater       Date:  2013-03-15       Impact factor: 8.947

8.  Extracellular UDP-glucose activates P2Y14 Receptor and Induces Signal Transducer and Activator of Transcription 3 (STAT3) Tyr705 phosphorylation and binding to hyaluronan synthase 2 (HAS2) promoter, stimulating hyaluronan synthesis of keratinocytes.

Authors:  Tiina A Jokela; Riikka Kärnä; Katri M Makkonen; Jarmo T Laitinen; Raija H Tammi; Markku I Tammi
Journal:  J Biol Chem       Date:  2014-05-20       Impact factor: 5.157

Review 9.  Matrix hyaluronan-activated CD44 signaling promotes keratinocyte activities and improves abnormal epidermal functions.

Authors:  Lilly Y W Bourguignon
Journal:  Am J Pathol       Date:  2014-05-09       Impact factor: 4.307

10.  Hyaluronidase from infective Ancylostoma hookworm larvae and its possible function as a virulence factor in tissue invasion and in cutaneous larva migrans.

Authors:  P J Hotez; S Narasimhan; J Haggerty; L Milstone; V Bhopale; G A Schad; F F Richards
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.